Plain-English translation of NCT06581861 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is following people who are genetically at risk for developing ALS (a serious neurological disease) but who don't currently have symptoms. Researchers will collect blood samples, health information, and other measurements over three years to understand what early warning signs might appear before symptoms develop. This information could help doctors identify and help people at risk before the disease progresses.
ALS is a serious disease that damages nerve cells and causes progressive weakness, but it's often diagnosed only after symptoms appear. By studying people who carry the genes that cause ALS before they get sick, researchers hope to find early warning signs and biomarkers that could lead to treatments to prevent or delay the disease.
You'll visit the clinic in person once a year (4 times total) and have remote visits by phone or video every four months (6 times total) over three years. At each visit, researchers will collect blood samples, review your medical history, ask you health questions, and record your speech. You'll also answer questionnaires about your health. If you choose, you can participate in an optional genetic testing sub-study that includes counseling about your results. All your samples and data will help researchers understand how ALS develops in people at genetic risk.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
United States